BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,491 | -20.5% | 866 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $54,731 | +40.5% | 866 | 0.0% | 0.01% | +33.3% |
| Q1 2023 | $38,961 | +2.7% | 866 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $37,939 | -33.4% | 866 | 0.0% | 0.01% | -36.4% |
| Q3 2022 | $57,000 | +29.5% | 866 | 0.0% | 0.01% | +22.2% |
| Q2 2022 | $44,000 | -20.0% | 866 | 0.0% | 0.01% | -10.0% |
| Q1 2022 | $55,000 | -40.9% | 866 | 0.0% | 0.01% | -41.2% |
| Q4 2021 | $93,000 | +4.5% | 866 | 0.0% | 0.02% | -5.6% |
| Q3 2021 | $89,000 | +17.1% | 866 | 0.0% | 0.02% | +12.5% |
| Q2 2021 | $76,000 | -19.1% | 866 | -10.4% | 0.02% | -23.8% |
| Q1 2021 | $94,000 | -13.0% | 966 | 0.0% | 0.02% | -16.0% |
| Q4 2020 | $108,000 | +20.0% | 966 | 0.0% | 0.02% | +13.6% |
| Q3 2020 | $90,000 | +20.0% | 966 | 0.0% | 0.02% | +15.8% |
| Q2 2020 | $75,000 | +33.9% | 966 | 0.0% | 0.02% | +18.8% |
| Q1 2020 | $56,000 | -27.3% | 966 | 0.0% | 0.02% | -11.1% |
| Q4 2019 | $77,000 | +8.5% | 966 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $71,000 | -22.0% | 966 | 0.0% | 0.02% | -21.7% |
| Q2 2019 | $91,000 | +18.2% | 966 | 0.0% | 0.02% | +15.0% |
| Q1 2019 | $77,000 | +48.1% | 966 | 0.0% | 0.02% | +42.9% |
| Q4 2018 | $52,000 | -30.7% | 966 | 0.0% | 0.01% | -30.0% |
| Q3 2018 | $75,000 | +23.0% | 966 | 0.0% | 0.02% | +17.6% |
| Q2 2018 | $61,000 | -54.5% | 966 | -34.1% | 0.02% | -54.1% |
| Q1 2018 | $134,000 | +20.7% | 1,466 | 0.0% | 0.04% | +15.6% |
| Q4 2017 | $111,000 | +8.8% | 1,466 | 0.0% | 0.03% | +3.2% |
| Q3 2017 | $102,000 | +37.8% | 1,466 | 0.0% | 0.03% | +29.2% |
| Q2 2017 | $74,000 | +25.4% | 1,466 | 0.0% | 0.02% | +26.3% |
| Q1 2017 | $59,000 | +43.9% | 1,466 | 0.0% | 0.02% | +35.7% |
| Q4 2016 | $41,000 | -6.8% | 1,466 | 0.0% | 0.01% | -6.7% |
| Q3 2016 | $44,000 | +46.7% | 1,466 | 0.0% | 0.02% | +50.0% |
| Q2 2016 | $30,000 | +15.4% | 1,466 | 0.0% | 0.01% | +11.1% |
| Q1 2016 | $26,000 | -55.2% | 1,466 | -33.2% | 0.01% | -57.1% |
| Q4 2015 | $58,000 | – | 2,196 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |